The global peri-implantitis treatment market is poised for substantial growth, with its valuation projected to increase from USD 2,689.1 million in 2024 to USD 5,191.9 million by 2034. This represents a robust compound annual growth rate (CAGR) of 6.8% over the forecast period. In 2023, the market was valued at USD 2,517.9 million, highlighting steady year-over-year growth as demand for effective treatment options continues to rise.
Peri-implantitis, a localized infectious condition affecting the soft and hard tissues around dental implants, poses a significant challenge to the stability and longevity of dental implants. As dental implants become a popular option for replacing missing teeth due to aesthetic and functional reasons, the incidence of peri-implantitis has increased. Bone loss caused by inflammation around the implant can significantly impact patient outcomes, necessitating timely and effective treatment.
The prevalence of peri-implantitis is notable, with studies from the National Center for Biotechnology Information (NCBI) indicating that 34% of patients with dental implants experience peri-implantitis, and 21% of dental implants are affected. This high prevalence underscores the critical need for advanced peri-implantitis treatment options. The growing focus on dental implant longevity, coupled with rising patient awareness of oral health, is driving the demand for effective treatments in dental care.
A Full Report Analysis – https://www.futuremarketinsights.com/reports/peri-implantitis-treatment-market
Key Takeaways:
- The global peri-implantitis treatment market is expected to grow from USD 2.69 billion in 2024 to USD 5.19 billion by 2034, with a CAGR of 6.8%.
- Rising adoption of dental implants for aesthetic and functional purposes has led to an increase in peri-implantitis cases worldwide.
- Studies indicate that 34% of dental implant patients experience peri-implantitis, with 21% of implants being affected, highlighting the urgency for treatment solutions.
- The market’s expansion is driven by the need for advanced treatment options to manage bone loss, ensure implant stability, and promote oral health.
As dental implants continue to gain popularity, the need for effective treatment of peri-implantitis will rise. With healthcare providers and dental professionals focused on improving patient outcomes and extending the lifespan of implants, the peri-implantitis treatment market is expected to see significant innovation and growth in the coming decade.
Key Drivers of Growth
- Rising Demand for Dental Implants: As dental implants become a popular solution for replacing missing teeth, the associated risk of peri-implantitis necessitates effective treatment options.
- Advancements in Treatment Options: The market is witnessing innovations in treatment methodologies, including both surgical and non-surgical approaches. These advancements are crucial for improving patient outcomes and enhancing the longevity of dental implants.
- Increased Awareness and Early Detection: Growing awareness among dental professionals and patients about peri-implantitis management is driving demand for timely interventions.
Competitive Landscape
To remain competitive, key producers in the peripheral microcatheter market are focused on a number of strategic initiatives. The key players are making major investments in R&D to improve materials and designs aimed at better performance and safety of the catheters. Companies are forming alliances with each other and acquiring smaller companies for broadening their product portfolios and accessing newly surfaced technologies.
Recent Industry Developments in peri-implantitis treatment Market
- On 6 July 2024, Fotona thrilled to announce the opening of the Laser & Health (LA&HA) Academy Training Center in Malaysia. Designed to support all Fotona users and practitioners, the new center aims to enhance knowledge, foster collaboration, and achieve clinical excellence. Modeled after the renowned LA&HA Training Center in Ljubljana, Slovenia, this new center boasts a top-tier curriculum and advanced training capabilities.
- On 23 Feb 2024, Straumann has announced the complete acquisition of GalvoSurge, a Swiss medical device company specializing in dental implant care and maintenance solutions. GalvoSurge has developed an innovative approach to support peri-implantitis treatment, with its CE-marked device launched in 2020.
Key Players of Peri-implantitis Treatment Industry
- Pfizer Inc.
- Cadila Pharmaceuticals
- R N. Laboratories
- Triveni Chemicals
- Basic Pharma Life Sciences
- Prachi Pharmaceuticals
- Healthy Life Pharma Private Limited
- Straumann AG
- Fotona
Key Segments of Peri-implantitis Treatment Industry
By Method Type:
In terms of method type, the industry is divided into surgical treatment of peri-implantitis (mechanical debridement, laser debridement, open flap debridement, open flap debridement with guided bone generation), non-surgical treatment of peri-implantitis (surface debridement, antibiotics (chlorhexidine digluconate), others.
By End User:
In terms of end user, the industry is segregated into peri-implantitis treatment in hospitals and peri-implantitis treatment in dental clinics
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Angio Suites Market
Point-of-care Cholesterol Monitoring Device Market
Airway Management Devices Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube